UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...
Allogene is ceasing enrollment in a Phase I trial of cema-cel for patients with relapsed or refractory chronic lymphocytic ...
Hosted on MSN9m
Russia Lost 194 Vehicles, 64 Artillery in One Day: KyivThe U.S. does fund bio labs in Ukraine, however, her detractors said at the time that she insinuated the U.S. is also funding ...
Zai Lab announces $200M share offering amid 47% revenue growth and plans for KarXT submission in China. Multiple companies report changes: Kronos Bio seeks alternatives, Allogene halts trial ...
Daily Express US on MSN47m
Trump's national intelligence director slammed as 'Russian asset and Hindu nationalist'Tulsi Gabbard, a former fringe Democrat turned Trump loyalist, was tapped by Donald Trump as the next National Intelligence ...
On Wednesday, BridgeBio Pharma Inc (BBIO) stock saw a modest uptick, ending the day at $24.79 which represents a slight increase of $0.17 or 0.69% from the prior close of $24.62. The stock opened at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback